[HTML][HTML] Abiraterone and increased survival in metastatic prostate cancer
…, TE Hutson, T Cheng, H Patterson… - … England Journal of …, 2011 - Mass Medical Soc
Background Biosynthesis of extragonadal androgen may contribute to the progression of
castration-resistant prostate cancer. We evaluated whether abiraterone acetate, an inhibitor of …
castration-resistant prostate cancer. We evaluated whether abiraterone acetate, an inhibitor of …
[HTML][HTML] Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority …
…, M Panades, C Parker, H Patterson… - The Lancet …, 2016 - thelancet.com
Background Prostate cancer might have high radiation-fraction sensitivity that would give a
therapeutic advantage to hypofractionated treatment. We present a pre-planned analysis of …
therapeutic advantage to hypofractionated treatment. We present a pre-planned analysis of …
[HTML][HTML] Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised …
…, P Mayles, O Naismith, C Parker, H Patterson… - The lancet …, 2012 - thelancet.com
Background Prostate cancer might have high radiation-fraction sensitivity, implying a therapeutic
advantage of hypofractionated treatment. We present a pre-planned preliminary safety …
advantage of hypofractionated treatment. We present a pre-planned preliminary safety …
[HTML][HTML] Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient …
…, C Parker, J Logue, C Scrase, H Patterson… - The Lancet …, 2015 - thelancet.com
Background Patient-reported outcomes (PROs) might detect more toxic effects of radiotherapy
than do clinician-reported outcomes. We did a quality of life (QoL) substudy to assess …
than do clinician-reported outcomes. We did a quality of life (QoL) substudy to assess …
[HTML][HTML] Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial …
…, A Law, C Loughrey, D McClaren, H Patterson… - European urology, 2020 - Elsevier
Background The ProtecT trial reported intention-to-treat analysis of men with localised prostate
cancer (PCa) randomly allocated to active monitoring (AM), radical prostatectomy, and …
cancer (PCa) randomly allocated to active monitoring (AM), radical prostatectomy, and …
Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257
…, DR Kuritzkes, TT Brown, KB Patterson… - Clinical Infectious …, 2015 - academic.oup.com
Background. Metabolic effects following combination antiretroviral therapy (cART) vary by
regimen type. Changes in metabolic effects were assessed following cART in the AIDS …
regimen type. Changes in metabolic effects were assessed following cART in the AIDS …
Improving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodes
D Plecha, S Bai, H Patterson, C Thompson… - Annals of surgical …, 2015 - Springer
Background This study aimed to evaluate whether the use of preoperative ultrasound (US)-guided
wire localization of metastatic axillary lymph nodes (LN) assessed previously by core …
wire localization of metastatic axillary lymph nodes (LN) assessed previously by core …
Pottery making in Upper Egypt: an ethnoarchaeological study
P Nicholson, H Patterson - World Archaeology, 1985 - Taylor & Francis
Despite the enormous importance of pottery to the archaeologist, detailed ethnoarchaeological
studies of pottery production are rare, and tend to concentrate on the most primitive forms …
studies of pottery production are rare, and tend to concentrate on the most primitive forms …
Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual …
…, A Law, C Loughrey, D McClaren, H Patterson… - BJU …, 2016 - Wiley Online Library
Objectives To present the baseline patient‐reported outcome measures ( PROM s) in the
Prostate Testing for Cancer and Treatment (ProtecT) randomized trial comparing active …
Prostate Testing for Cancer and Treatment (ProtecT) randomized trial comparing active …
Three south Etrurian 'crises': First results of the Tiber Valley project
H Patterson, H Di Giuseppe, R Witcher - Papers of the British School …, 2004 - cambridge.org
Since 1997 the focus of the British School at Rome's archaeology programme has been the
Tiber Valley Project. The five-year Leverhulme-funded phase of this project drew to a close …
Tiber Valley Project. The five-year Leverhulme-funded phase of this project drew to a close …